These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 13011195)

  • 1. Intravenous trypsin; its anticoagulant, fibrinolytic and thrombolytic effects.
    INNERFIELD I; SCHWARZ A; ANGRIST A
    J Clin Invest; 1952 Dec; 31(12):1049-55. PubMed ID: 13011195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic and anticoagulant effects of intravenous crystalline trypsin.
    INNERFIELD I; SCHWARTZ AW; ANGRIST AA
    Bull N Y Acad Med; 1952 Aug; 28(8):537-8. PubMed ID: 14935511
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant and fibrinolytic activities in vitro and in vivo of mucopolysaccharides of the aorta].
    LOMBARDI V; GUIDI G; SCARDIGLI G; ZINI F
    G Gerontol; 1961 Dec; 9():1143-54. PubMed ID: 14466406
    [No Abstract]   [Full Text] [Related]  

  • 5. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic principles of fibrinolytic therapy].
    Markwardt F
    Z Gesamte Inn Med; 1987 Sep; 42(17):473-8. PubMed ID: 3318182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A; Lampugnani P
    Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
    Alvarez Bravo G; Orts Castro E; Carvalho Monteiro G; López Zuazo I
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):e192-e193. PubMed ID: 28663010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis, fibrinolysis, and coagulation. Significance in thrombolytic therapy.
    ALEXANDER B; PECHET L; KLIMAN A
    Circulation; 1962 Oct; 26():596-611. PubMed ID: 14011937
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator.
    Fassbender K; Dempfle CE; Mielke O; Schwartz A; Daffertshofer M; Eschenfelder C; Dollman M; Hennerici M
    Stroke; 1999 Oct; 30(10):2101-4. PubMed ID: 10512913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RESEARCH ON THE ANTICOAGULANT AND FIBRINOLYTIC ACTION IN VIVO OF HIRUDIN].
    GIBELLI A
    Riv Patol Clin; 1963 Sep; 18():505-19. PubMed ID: 14108839
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolysis and the bovine lung trypsin inhibitor ("Pulmin").
    Egeblad K; Astrup T
    Scand J Clin Lab Invest; 1966; 18(6):567-76. PubMed ID: 4225248
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulant-antithrombin and fibrinolytic actions of extract of marine alga Corallina rubens L.
    Güven KC; Ulutin SB; Mutluay E; Ulutin ON
    Haemostasis; 1973-1974; 2(6):260-8. PubMed ID: 4802400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of anticoagulant and fibrinolytic effects of glyprolines Gly-Pro and Gly-Pro-Arg in conditions of immobilization stress].
    Grigor'eva ME; Liapina LA; Andreeva LA; Miasoedov NF
    Izv Akad Nauk Ser Biol; 2009; (5):585-90. PubMed ID: 19894599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytics: drug interactions of clinical significance.
    Harder S; Klinkhardt U
    Drug Saf; 2000 Nov; 23(5):391-9. PubMed ID: 11085346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and Function of Trypsin-Loaded Fibrinolytic Liposomes.
    Tanka-Salamon A; Bóta A; Wacha A; Mihály J; Lovas M; Kolev K
    Biomed Res Int; 2017; 2017():5130495. PubMed ID: 28758116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.